Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory ...

Abbott’s Q2 showed resilience amid macro risks, with its dividend strength and fair valuation reinforcing long-term appeal.

Read about how to grow resilient passive income with a balanced dividend growth strategy, focusing on quality, stability, and ...

APA Corp. is generating strong cash flow, reducing debt. APA stock offers a 5.5% dividend yield, making it a compelling ...

Visa upgraded to 'Buy' for strong financials, evolving B2B focus, exceptional profitability, and reliable growth, despite ...

Arbor Realty’s dividend cut and weak coverage keep me neutral on common shares, despite strong origination and NPL ...

Jussi Askola is the President of Leonberg Capital, a value-oriented investment boutique that consults hedge funds, family ...

Gulfport trimmed 2025 output guidance after midstream issues but shows solid well results and cuts dilution via $379M ...

Warner Bros. Discovery outpaces the S&P 500 with streaming growth, strong financials, and global appeal. Read here for an ...

ULTY offers a 126% yield by targeting volatile sectors for option income, but long-term risks and NAV decline limit appeal.

Lucid posted deeper Q2 losses and cut its 2025 outlook, but strong liquidity and a key Uber deal support long-term growth. Find out why LCID stock is a buy.

Compare GPIQ and JEPQ covered call ETFs for high yields and Nasdaq-100 tech exposure. Learn why GPIQ stands out despite capped upside and risks.